What dose and target volume do you use for neoadjuvant chemoRT in a patient with a locally advanced uterine/endometrial cancer involving parametria, cervix, and the uterine fundus (no side wall involvement) requiring downstage to be eligible for surgery?
Her primary disease is too large for any brachytherapy; if substantial residual disease remains, how would you approach external beam boost?